Improving therapeutic effectiveness and safety through big healthcare data
Author:
Affiliation:
1. Division of Pharmacoepidemiology, Department of Medicine; Brigham & Women's Hospital and Harvard Medical School; Boston Massachusetts USA
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.316/fullpdf
Reference10 articles.
1. A review of uses of health care utilization databases for epidemiologic research on therapeutics;Schneeweiss;J. Clin. Epidemiol.,2005
2. Evaluating discrimination of risk prediction models: the C statistic;Pencina;JAMA,2015
3. A case for why health systems should partner with pharmacies;Shrank;Harvard Business Review,2015
4. Developments in post-marketing comparative effectiveness research;Schneeweiss;Clin. Pharmacol. Ther.,2007
5. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy;Tunis;JAMA,2003
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Analysis of a National Database Investigating Development of Trigger Finger after Treatment of Dupuytren Disease;Plastic and Reconstructive Surgery - Global Open;2023-06
2. An Attempt to Replicate Randomized Trials of Diabetes Treatments Using a Japanese Administrative Claims and Health Checkup Database: A Feasibility Study;Drugs - Real World Outcomes;2023-02-01
3. Impact of "time zero" of Follow-Up Settings in a Comparative Effectiveness Study Using Real-World Data with a Non-user Comparator: Comparison of Six Different Settings;Drugs - Real World Outcomes;2022-11-28
4. Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors Versus Metformin;Annals of Internal Medicine;2022-07
5. Evolving channeling in prescribing SGLT ‐2 inhibitors as first‐line treatment for type 2 diabetes;Pharmacoepidemiology and Drug Safety;2022-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3